NPS Pharmaceuticals (NASDAQ:NPSP) had its price target upped by Canaccord Genuity from $35.00 to $42.00 in a research note issued to investors on Monday, American Banking News reports. The firm currently has a buy rating on the stock. In other NPS Pharmaceuticals news, CFO Luke Beshar sold 37,874 shares of the stock in a transaction […]
NPS Pharmaceuticals Price Target Raised to $42.00 at Canaccord Genuity (NPSP) is a post from: Zolmax
The post NPS Pharmaceuticals Price Target Raised to $42.00 at Canaccord Genuity (NPSP) appeared first on Zolmax.